Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDNF | P23560 | 3/20 | 0.40 |
| ▸ | PTN | P21246 | 2/20 | 0.40 |
| ▸ | MDK | P21741 | 2/20 | 0.40 |
| ▸ | F10 | P00742 | 2/20 | 0.35 |
| ▸ | LGALS3 | P17931 | 7/20 | 0.35 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.35 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.35 |
| ▸ | LGALS7; LGALS7B | P47929 | 2/20 | 0.33 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.33 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.32 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.32 |
| ▸ | FGF1 | P05230 | 1/20 | 0.32 |
| ▸ | BMP2 | P12643 | 2/20 | 0.32 |
| ▸ | VEGFA | P15692 | 2/20 | 0.32 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.32 |
| ▸ | SHH | Q15465 | 2/20 | 0.32 |
| ▸ | IFNG | P01579 | 1/20 | 0.32 |
| ▸ | PF4 | P02776 | 1/20 | 0.32 |
| ▸ | CCL2 | P13500 | 1/20 | 0.32 |
| ▸ | SELP | P16109 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18936352 | 0.91 | LGALS3 (0.43) | BDNFPTNMDKLGALS3LGALS8 | |
| SCHEMBL19325099 | 0.91 | LGALS3 (0.43) | BDNFPTNMDKLGALS3LGALS8 | |
| SCHEMBL21908706 | 0.86 | LGALS3 (0.41) | BDNFPTNMDKLGALS3LGALS8 | |
| SCHEMBL16248154 | 0.83 | BDNF (0.45) | BDNFPTNMDKF10LGALS3 | |
| SCHEMBL16884736 | 0.83 | BDNF (0.45) | BDNFPTNMDKF10LGALS3 | |
| SCHEMBL20290392 | 0.82 | LGALS3 (0.42) | BDNFPTNMDKLGALS3LGALS8 | |
| SCHEMBL21316642 | 0.81 | LGALS3 (0.42) | BDNFPTNMDKLGALS3LGALS8 | |
| SCHEMBL22472735 | 0.81 | LGALS3 (0.42) | BDNFPTNMDKLGALS3LGALS8 | |
| SCHEMBL18737220 | 0.81 | LGALS3 (0.42) | BDNFPTNMDKLGALS3LGALS8 | |
| SCHEMBL20122304 | 0.81 | LGALS3 (0.42) | BDNFPTNMDKLGALS3LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11229656-B2 | Hyaluronan conjugates with pharmaceutically active substances, methods and compositions | SYNARTRO AB (SE) | 2022-01-25 | — | — | US | disclosed |
| US-20200237783-A1 | HYALURONAN CONJUGATES WITH PHARMACEUTICALLY ACTIVE SUBSTANCES, METHODS AND COMPOSITIONS | SYNARTRO AB (SE) | 2020-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200237783-A1 | HYALURONAN CONJUGATES WITH PHARMACEUTICALLY ACTIVE SUBSTANCES, METHODS AND COMPOSITIONS | CD44, PIGS, HPSE | BDNF 1078/4885PTN 475/4885MDK 604/4885 |
| US-11229656-B2 | Hyaluronan conjugates with pharmaceutically active substances, methods and compositions | CD44, PIGS, HPSE | BDNF 1078/4885PTN 475/4885MDK 604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.